We have integrated preparative twodimensional polyacrylamide gel electrophoresis with highperformance tandem mass spectrometry and Edman degradation. By using this approach, we have isolated and identified, by partial sequencing, a human melanoma protein (34 kDa, pI 6.4) as lipocortin I. To our knowledge, this protein was not previously known to be associated with melanoma cells. The identity of the protein was confirmed by two-dimensional immunoblot analysis. High-energy colsion-induced dissociation analysis revealed the sequence and acetylation of the N-terminal tryptic peptide and an acrylamide-modifled cysteine in another trptic peptide. Thus, knowledge concerning both the primary structure and covalent modifications of proteins isolated from two-dimensional gels can be obtained directly by this approach, which is applicable to a broad range of biological problems.
performance tandem mass spectrometry and Edman degradation. By using this approach, we have isolated and identified, by partial sequencing, a human melanoma protein (34 kDa, pI 6.4) as lipocortin I. To our knowledge, this protein was not previously known to be associated with melanoma cells. The identity of the protein was confirmed by two-dimensional immunoblot analysis. High-energy colsion-induced dissociation analysis revealed the sequence and acetylation of the N-terminal tryptic peptide and an acrylamide-modifled cysteine in another trptic peptide. Thus, knowledge concerning both the primary structure and covalent modifications of proteins isolated from two-dimensional gels can be obtained directly by this approach, which is applicable to a broad range of biological problems. Two-dimensional polyacrylamide gel electrophoresis (2D PAGE), coupled with microsequencing techniques and the establishment of protein data bases, has proven to be a powerful and sensitive strategy for the detection, purification, and identificatidn of individual proteins from complex mixtures of cellular proteins. In fact, the application of these methods is viewed as both essential and complementary to efforts directed toward mapping and sequencing the entire human genome (1) (2) (3) . As an analytical technique, 2D PAGE is unequaled in its ability to simultaneously resolve hundreds of proteins from cellular extracts and provide data on their isoelectric points, putative molecular weights, relative abundance, and electrophoretic pattern (4, 5) . Utilizing advances in computer-based gel analysis, this laboratory (6) (7) (8) (9) and other investigators (10) (11) (12) have created protein data bases consisting of catalogues of proteins that characterize a variety of cell and tissue types at the molecular level. Specifically, we have exploited this technology to characterize proteins whose synthesis is regulated by cytokines such as the interferons (IFNs), interleukins, and tumor necrosis factor (TNF) in several cell types, including human fibroblasts (6), ME-180 cervical carcinoma (7) , and A375 melanoma cells (9) . Extensive data bases exist for human amnion cells (10) , rat fibroblasts (11) , and Escherichia coli (12) . The identification and sequencing of these proteins is of major importance because some may regulate cell cycle events and/or represent cytokine or hormonal effects, metastatic potential, tissue-specific functions, or unique structural elements.
Conventional methods of sequencing proteins after purification by 2D PAGE include electroblotting proteins to nitrocellulose or poly(vinylidene difluoride) membranes and N-terminal Edman degradation (1, 3, (13) (14) (15) . Using this approach, we have sequenced two IFN-y-induced proteins from human fibroblasts, Mn superoxide dismutase (13) and leucine aminopeptidase (14) . Unfortunately, 80-90% ofmammalian proteins are acetylated or otherwise modified at their N termini and, consequently, are resistant to Edman degradation (16 (1, 3, (17) (18) (19) . Although these techniques can be reliable, they do not identify posttranslational and chemical modifications. Thus, it was vital to design a protocol to overcome these problems and those that result from the lack of information represented by a blank cycle in Edman degradation or a failure to obtain all peptides generated by cleavage, a problem inherent in immobilized protein digestion procedures. A complete characterization of the structure of proteins isolated by 2D PAGE is essential to an understanding of the biochemistry of a given cell type and how that cell responds to a variety of stimuli.
In recent years, liquid secondary ion mass spectrometry (LSIMS) and tandem mass spectrometry (MS/MS) using both low-and high-energy collision-induced dissociation (CID) have been applied to a variety of biological structural problems (20, 21) . These range from peptide mapping to identification of post-translational modifications, such as N-terminal blocking groups (20, (22) (23) (24) , phosphorylation (25, 26) , and glycosylation (24, 27, 28 (4), as modified by Patton et al. (33) and by our laboratory (8), using the Investigator 2D electrophoresis system (Millipore). Preparative gels were used to obtain purified preparations of individual melanoma proteins for sequencing. The methods are similar to those described for analytical gels with the following modifications. Whole cell lysates containing 750-1000 ,ug of protein were focused for 17.5 h at 1000 V and then for 30 min at 2000 V on prefocused 3-mm tube gels containing 8.5 M urea, 4% (vol/vol) acrylamide/bis solution (Millipore), 5.5% ampholytes, and 2% n-octyl glucoside. Tube gels were then equilibrated for 30 min and placed in alignment guides on top of 1-mm-thick 10%o or 12.5% polyacrylamide/SDS slab gels (pH 8.8), containing a 3-cm stacking gel (pH 6.8) of 4% or 6% acrylamide/bis solution, and electrophoresed for 5-6 h at 16 W per gel. Sodium thioglycolate (0.1 mM) was included in the running buffer of the second dimension to scavenge free radicals or oxidants trapped in the gel matrix (34) . Gels were fixed overnight in 50% (vol/vol) methanol/3% (vol/vol) H3PO4, washed twice in H20 (HPLC grade) for 15 min, and stained for 24 h in 509o methanol/3% H3PO4/17% (vol/vol) (NH4)2SO4/0.1% Coomassie blue G250. Gels were destained with H20 and protein gel spots were excised with a scalpel.
Isolation and Purification of Proteins from 2D Gels. Electroelution was performed at 23°C in an apparatus designed by Hunkapiller et al. (34) and fitted with a Spectra-Por dialysis membrane (8-kDa cut off) washed with H20 prior to use. Gel slices were diced in H20 without exposure to any SDS buffer to prevent protein loss. N-Ethylmorpholine acetate (NEMOAc, pH 8.2) was used as the buffer component, since fewer bubbles were formed with NEMOAc and less residue was left after lyophilization than with ammonium bicarbonate buffer.
Before enzymatic digestion, an acetone precipitation using solvent system A (35) 
RESULTS AND DISCUSSION
A typical 2D preparative gel separation of human A375 melanoma proteins is illustrated in Fig. 1 . A protein having the molecular mass and isoelectric point of 34 kDa and 6.4, respectively, was isolated from 6 to 18 gels and partially sequenced using both mass spectrometric and Edman protocols on three occasions. We identified it as lipocortin I by matching experimentally determined tryptic peptide sequences to those of proteins catalogued in the Protein Identification Resource data base (40) . The sequence corresponds to that of Wallner et al. (41) . Four of our sequences were determined by MS/MS and five sequences were determined by Edman degradation. Fig. 2 depicts the amino acid sequence of human lipocortin I derived by cDNA sequence analysis (41) . The peptides that we sequenced by high-energy CID are underlined with a bold bar and the peptides sequenced by Edman degradation are underlined twice. Four additional HPLC fractions contained components whose molecular ion masses matched the predicted monoisotopic molecular ion (MH+) masses corresponding to other protonated lipocortin I tryptic peptides (underlined once). These latter peptides were recovered at levels too low to obtain sequence data by MS/MS or by Edman Fig. 3 . The sequence of this peptide was established by a complete C-terminal y-ion series I I as wel as a nearly complete N-terminal b-ion series. This allowed us to take advantage of another unique feature of mass spectrometric sequencing. Once the C-terminal sequence had been established, it was verified by identifying additional masses representative of peptide backbone cleavages originating from the N terminus. Also, all of the N-terminal fragment ions found for this peptide are 42 Da greater than that predicted. This mass difference corresponds to the incremental mass of an acetyl moiety and thus establishes its presence on the N-terminal alanine of lipocortin I. Currently, MS/MS is the only method available capable of readily sequencing peptides that are acetylated at their N terminus (20, (22) (23) (24) 48) . In fact, human placental and E. coliexpressed human lipocortin I have been shown (48) predicted lipocortin I tryptic peptide. However, interpretation of the CID spectrum of this component (Fig. 4) revealed that it was the tryptic peptide CLTAIVK, residues 262-268 of lipocortin I, in which the cysteine had been covalently modified by an acrylamide moiety ofincremental mass 72 Da. The sequence of this peptide was clearly established by the presence of a complete C-terminal y-ion series as well as an almost complete N-terminal b-ion series. Isoleucine rather than leucine is established as the fifth residue by the appropriate v and w ions present at masses 485.2 and 498.3 Da, respectively. Ions produced by side-chain fragmentation present at masses 774.4, 746.5, 713.4, and 700.5 Da proved that the modification is an acrylamide moiety bound to the cysteine sulfur atom rather than an N-terminal alanine residue. Acrylamide and an N-terminal alanine have identical atomic compositions and molecular weights. To our knowledge, this acrylamide-modified amino acid residue provides the first direct proof that proteins can be covalently modified during electrophoresis. It is essential that this type of covalent modification be considered when interpreting CID data of proteins isolated from polyacrylamide gels.
LSIMS analysis of several HPLC fractions exhibiting substantial absorbance peaks did not produce molecular ions, possibly because of the presence ofunanticipated impurities. During our initial attempts at sequencing lipocortin I, LSIMS analysis showed a nonpeptide component that gave a mass spectrum similar to a polyethylene glycol mixture. Subsequent analysis showed that the most probable source was residual Nonidet P-40, a detergent mixture originally used in the preparation of melanoma cell lysates. Once Nonidet P-40 was replaced with 3-octyl glucoside, subsequent preparations were free of this contaminant. Moreover, HPLC fractions containing the five tryptic peptides of IThroughout the text the nomenclature first proposed by Roepstroff and Fohlman (42) and modified by Biemann (43) were sequenced by the Edman degradation gave no molecular weight information by LSIMS. It is possible that more hydrophobic impurities present in the fractions resulted in a suppression of peptide ionization due to their greater surface activity (44) . Thus, data obtained by Edman degradation complemented, but did not duplicate, sequence data obtained by mass spectrometry. One potential problem in microsequencing peptides of a protein containing several cysteines is that they usually have formed disulfide bridges and subsequently limit enzymatic digestion or result in two peptides that are disulfide-linked. Although lipocortin I contains four cysteine residues that presumably can form disulfide bridges (41) , if present, they did not interfere with our ability to digest the protein with trypsin nor with our ability to identify the protein using MS/MS or Edman degradation.
The identity ofthe protein we sequenced as lipocortin I was also confirmed by 2D immunoblot analysis. Fig. SA shows the autoradiogram of the 2D A375 melanoma protein blot that contains lipocortin I. The arrow points to the larger spot that has the molecular mass and pI coordinates that match those of the protein that we excised from preparative gels for sequencing. The same area is depicted in Fig. SB after the blot was probed with a monoclonal antibody specific to human lipocortin I. The result clearly demonstrates that the protein we selected for sequencing is lipocortin I. Another spot of lesser intensity also reacted with the monoclonal antibody and probably represents another form of lipocortin I. Lipocortin I contains potential phosphorylation sites (41) (46) in several other cell types treated with TNF. The constitutive presence of lipocortin I in melanoma cells is of particular importance, as it is known to block phospholipase A2 activity (45) , a key molecule in the signal pathway of TNF (47) .
In summary, by integrating preparative 2D PAGE with Edman degradation and MS/MS, we have isolated and identified lipocortin I, to our knowledge, a protein previously not known to be associated with melanoma cells. Specific covalent modifications, an acetylated N terminus and an acrylamide-modified cysteine residue, were determined by MS/MS. The combination of these technologies maximizes the amount of information pertaining to the sequence and primary structural modifications of a given protein. This combined approach could be applied to the creation of a multitude of protein data bases and should be of considerable utility in complementing data obtained from the Human Genome Project, as partial sequences of unknown proteins can be used to generate specific oligonucleotides that can then be used to isolate and clone unidentified genes from cDNA libraries. Also, it could be applied to a broad range of 
